For cancer, a natural or synthetic anti-inflammatory, but not both

For cancer, a natural or synthetic anti-inflammatory, but not both

A synthetic anti-inflammatory reduced the cancer-fighting effect of a well-known, natural compound found in turmeric.

While certain things are greater than the sum of their parts, this seems not to be the case with some cancer treatments. Rath...

Related Publication

Celecoxib prevents curcumin-induced apoptosis in a hematopoietic cancer cell model

Cyril Sobolewski Florian Muller Claudia Cerella Mario Dicato Marc Diederich

Published in Molecular Carcinogenesis

Author

5334 0
Lutte contre le cancer : anti-inflammatoire naturel ou synthétique, il faut choisir !

Lutte contre le cancer : anti-inflammatoire naturel ou synthétique, il faut choisir !

Un anti-inflammatoire synthétique réduit l’action anticancéreuse d’une substance naturelle bien connue, extraite du curcuma

Si dans certaines situations, le tout est plus grand que la somme des parties, cela ne semble pas être le cas pour certains t...

Related Publication

Celecoxib prevents curcumin-induced apoptosis in a hematopoietic cancer cell model

Cyril Sobolewski Florian Muller Claudia Cerella Mario Dicato Marc Diederich

Published in Molecular Carcinogenesis

Author

38440 0
Cardiac Drugs Against Cancer: Deciphering Their Action in the Cell

Cardiac Drugs Against Cancer: Deciphering Their Action in the Cell

Cancer researchers at the LBMCC lab in Luxembourg have identified the mechanism of action of a new anticancer drug

A family of naturally occurring plant compounds traditionally used to treat cardiac problems has also shown powerful effects...

Related Publication

Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450

Claudia Cerella Florian Muller Anthoula Gaigneaux Flavia Radogna Elodie Viry Sébastien Chateauvieux Mario Dicato Marc Diederich

Published in Cell Death and Disease

Author

11657 2
Les digitaliques, du cœur au cancer

Les digitaliques, du cœur au cancer

Des chercheurs contre le cancer au laboratoire LBMCC à l’hôpital du Kirchberg ont identifié le mécanisme d’action d’un nouveau médicament anticancéreux.

Une famille de composés naturels végétaux utilisés traditionnellement dans le traitement de maladies cardiaques s’avère avoir...

Related Publication

Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450

Claudia Cerella Florian Muller Anthoula Gaigneaux Flavia Radogna Elodie Viry Sébastien Chateauvieux Mario Dicato Marc Diederich

Published in Cell Death and Disease

Author

3972 1
Enhanced Repository from MyScienceWork Gives Lab LBMCC a Visibility Toolkit

Enhanced Repository from MyScienceWork Gives Lab LBMCC a Visibility Toolkit

Dr. Marc Diederich, head of the Luxembourg lab LBMCC, shares his motivations and expectations for his team’s new multi-functional communication platform

Today marks the launch of one lab’s new face on the Internet, as well as MyScienceWork’s brand new Enhanced Repositories for...

Author

6741 0
Epigenetics & Cancer: When Cells Refuse to Fade Away

Epigenetics & Cancer: When Cells Refuse to Fade Away

How DNA methylation could let leukemia cells avoid normal end-of-life senescence

Cells, like people, are meant to grow old and die. The fact that cancer cells are able to break this rule, avoiding the perio...

Related Publication

5-aza-2′-deoxycytidine-mediated c-myc Down-regulation Triggers Telomere-dependent Senescence by Regulating Human Telomer...

Cindy Grandjenette Michael Schnekenburger Tommy Karius Jenny Ghelfi Anthoula Gaigneaux Estelle Henry Mario Dicato Marc Diederich

Author

6017 2